FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361281561> ?p ?o ?g. }

• W4361281561 endingPage "10511" @default.
• W4361281561 startingPage "10499" @default.
• W4361281561 abstract "Abstract Objective To investigate the differences in efficacy and safety between haploidentical donor hematopoietic stem cell transplantation (HID‐HSCT) and matched sibling donor HSCT (MSD‐HSCT) in patients with T‐cell lymphoblastic lymphoma (T‐LBL). Methods In this retrospective analysis, we enrolled 38 patients who had undergone allogeneic HSCT at our institution between 2013 and 2021. The study participants included 28 patients who underwent HID‐HSCT and 10 patients who underwent MSD‐HSCT. We compared the patient characteristics and treatment effectiveness and safety between the two groups and evaluated potential prognostic variables for patients with T‐LBL. Results The median follow‐up durations in the HID‐HSCT and MSD‐HSCT groups were 23.5 (range: 4–111) and 28.5 (range: 13–56) months, respectively. All patients showed full‐donor chimerism after hematopoietic stem cell transplantation (HSCT). Except for two patients in the HID‐HSCT cohort who developed poor graft function, all patients showed neutrophil and platelet engraftments after HSCT. The cumulative incidences of grades III–IV acute graft‐versus‐host disease were 37.5% and 28.57% in the HID‐HSCT and MSD‐HSCT groups, respectively ( p = 0.84). The cumulative incidences of limited (34.13% vs. 28.57%, p = 0.82) and extensive (31.22% vs. 37.50%, p = 0.53) chronic graft‐versus‐host disease did not differ between the two cohorts. In the HID‐HSCT and MSD‐HSCT cohorts, the estimated 2‐year overall survival rates were 70.3% (95% confidence interval [CI]: 54.9%–90.0%) and 56.2% (95% CI: 31.6%–100%), respectively ( p = 1.00), and the estimated 2‐year progression‐free survival (PFS) rates were 48.5% (95% CI: 32.8%–71.6%) and 48.0% (95% CI: 24.6%–93.8%), respectively ( p = 0.94). Furthermore, the Cox proportional‐hazards model showed that a positive positron emission tomography/computed tomography (PET/CT) status before HSCT in patients who had completed chemotherapy was an independent risk factor for PFS in the multivariate analysis ( p = 0.0367). Conclusion This study showed that HID‐HSCT had comparable effectiveness and safety to MSD‐HSCT in treating T‐LBL. HID‐HSCT could serve as an alternate treatment option for T‐LBL in patients without an eligible identical donor. Achievement of the PET/CT‐negative status before HSCT may contribute to better survival." @default.
• W4361281561 created "2023-03-31" @default.
• W4361281561 creator A5000352976 @default.
• W4361281561 creator A5007096885 @default.
• W4361281561 creator A5014542823 @default.
• W4361281561 creator A5026192010 @default.
• W4361281561 creator A5039975734 @default.
• W4361281561 creator A5060222940 @default.
• W4361281561 creator A5073965149 @default.
• W4361281561 creator A5077693437 @default.
• W4361281561 creator A5079163183 @default.
• W4361281561 creator A5085754733 @default.
• W4361281561 creator A5091859656 @default.
• W4361281561 date "2023-03-29" @default.
• W4361281561 modified "2023-09-26" @default.
• W4361281561 title "Comparison of efficacies of haploidentical transplantation and matched sibling donor transplantation in treating T‐cell lymphoblastic lymphoma" @default.
• W4361281561 cites W1491993932 @default.
• W4361281561 cites W193514409 @default.
• W4361281561 cites W1954992673 @default.
• W4361281561 cites W1970373743 @default.
• W4361281561 cites W1972105236 @default.
• W4361281561 cites W2000402065 @default.
• W4361281561 cites W2006083195 @default.
• W4361281561 cites W2007246094 @default.
• W4361281561 cites W2047467924 @default.
• W4361281561 cites W2053278212 @default.
• W4361281561 cites W2083658950 @default.
• W4361281561 cites W2094813925 @default.
• W4361281561 cites W2104165703 @default.
• W4361281561 cites W2119147717 @default.
• W4361281561 cites W2122780124 @default.
• W4361281561 cites W2131983461 @default.
• W4361281561 cites W2141819662 @default.
• W4361281561 cites W2196003008 @default.
• W4361281561 cites W2276688320 @default.
• W4361281561 cites W2289642929 @default.
• W4361281561 cites W2300689292 @default.
• W4361281561 cites W2310716991 @default.
• W4361281561 cites W2342244830 @default.
• W4361281561 cites W2379365975 @default.
• W4361281561 cites W2396350328 @default.
• W4361281561 cites W2471705756 @default.
• W4361281561 cites W2598700764 @default.
• W4361281561 cites W2737210148 @default.
• W4361281561 cites W2809164184 @default.
• W4361281561 cites W2811351313 @default.
• W4361281561 cites W2837193188 @default.
• W4361281561 cites W2920559171 @default.
• W4361281561 cites W2948751210 @default.
• W4361281561 cites W3034729669 @default.
• W4361281561 cites W3059279585 @default.
• W4361281561 cites W3111466059 @default.
• W4361281561 cites W3114319385 @default.
• W4361281561 cites W3118439476 @default.
• W4361281561 cites W3147565893 @default.
• W4361281561 cites W3160418865 @default.
• W4361281561 cites W3200019819 @default.
• W4361281561 cites W3205085405 @default.
• W4361281561 cites W3215973842 @default.
• W4361281561 cites W4211099466 @default.
• W4361281561 cites W4361281561 @default.
• W4361281561 cites W853076665 @default.
• W4361281561 doi "https://doi.org/10.1002/cam4.5786" @default.
• W4361281561 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36992548" @default.
• W4361281561 hasPublicationYear "2023" @default.
• W4361281561 type Work @default.
• W4361281561 citedByCount "1" @default.
• W4361281561 countsByYear W43612815612023 @default.
• W4361281561 crossrefType "journal-article" @default.
• W4361281561 hasAuthorship W4361281561A5000352976 @default.
• W4361281561 hasAuthorship W4361281561A5007096885 @default.
• W4361281561 hasAuthorship W4361281561A5014542823 @default.
• W4361281561 hasAuthorship W4361281561A5026192010 @default.
• W4361281561 hasAuthorship W4361281561A5039975734 @default.
• W4361281561 hasAuthorship W4361281561A5060222940 @default.
• W4361281561 hasAuthorship W4361281561A5073965149 @default.
• W4361281561 hasAuthorship W4361281561A5077693437 @default.
• W4361281561 hasAuthorship W4361281561A5079163183 @default.
• W4361281561 hasAuthorship W4361281561A5085754733 @default.
• W4361281561 hasAuthorship W4361281561A5091859656 @default.
• W4361281561 hasBestOaLocation W43612815611 @default.
• W4361281561 hasConcept C126322002 @default.
• W4361281561 hasConcept C138496976 @default.
• W4361281561 hasConcept C141071460 @default.
• W4361281561 hasConcept C15744967 @default.
• W4361281561 hasConcept C167135981 @default.
• W4361281561 hasConcept C203014093 @default.
• W4361281561 hasConcept C2776090121 @default.
• W4361281561 hasConcept C2776194465 @default.
• W4361281561 hasConcept C2777408962 @default.
• W4361281561 hasConcept C2777478502 @default.
• W4361281561 hasConcept C2779338263 @default.
• W4361281561 hasConcept C2779972918 @default.
• W4361281561 hasConcept C2911091166 @default.
• W4361281561 hasConcept C44249647 @default.
• W4361281561 hasConcept C71924100 @default.
• W4361281561 hasConcept C72563966 @default.
• W4361281561 hasConcept C88879693 @default.

• next